Applied Health Sciences (Department)
Permanent URI for this communityhttps://hdl.handle.net/2164/632
Browse
37 results
Search Results
Item A Timely shift from shotgun to targeted proteomics and how it can be groundbreaking for cancer research(2017-02-20) Faria, Sara S.; Morris, Carlos F. M.; Silva, Adriano R.; Fonseca, Micaella P.; Forget, Patrice; Castro, Mariana S.; Fontes, Wagner; University of Aberdeen.Other Applied Health SciencesItem The effect of diabetes on the risk of endometrial Cancer : an updated a systematic review and meta-analysis(2019-05-31) Saed, Lotfolah; Varse, Fatemeh; Baradaran, Hamid Reza; Moradi, Yousef; Khateri, Sorour; Friberg, Emilie; Khazaei, Zaher; Gharahjeh, Saeedeh; Tehrani, Shahrzad; Sioofy-Khojine, Amir-Babak; Najmi, Zahra; University of Aberdeen.Other Applied Health SciencesItem Engaging high-risk groups in early lung cancer diagnosis : a qualitative study of symptom presentation and intervention preferences amongst the UK’s most deprived communities(2019) McCutchan, Grace M.; Hiscock, Julia; Hood, Kerenza; Murchie, Peter; Neal, Richard D.; Newton, Gareth; Thomas, Sara; Thomas, Ann-Maria; Brain, Kate; University of Aberdeen.Other Applied Health Sciences; University of Aberdeen.Grampian Data Safe Haven (DaSH); University of Aberdeen.Institute of Applied Health SciencesItem Proton pump inhibitor and histamine-2 receptor antagonist use and risk of liver cancer in two population-based studies(2018-07) Tran, Kim Tu; McMenamin, Úna C.; Hicks, Blánaid; Murchie, Peter; Thrift, Aaron P.; Coleman, Helen G.; Iversen, Lisa; Johnston, Brian T.; Lee, Amanda J.; Cardwell, Chris R.; University of Aberdeen.Other Applied Health Sciences; University of Aberdeen.Grampian Data Safe Haven (DaSH); University of Aberdeen.Institute of Applied Health Sciences; University of Aberdeen.Medical StatisticsItem Medications that relax the lower oesophageal sphincter and risk of oesophageal cancer : An analysis of two independent population-based databases(2018-07-01) Spence, Andrew D; Busby, John; Murchie, Peter; Kunzmann, Andrew T; McMenamin, Úna C; Coleman, Helen G; Johnston, Brian T; O'Rorke, Michael A; Murray, Liam J; Iversen, Lisa; Lee, Amanda Jane; Cardwell, Chris R; University of Aberdeen.Other Applied Health Sciences; University of Aberdeen.Grampian Data Safe Haven (DaSH); University of Aberdeen.Institute of Applied Health Sciences; University of Aberdeen.Medical StatisticsItem Pilot randomised controlled trial of Weight Watchers® referral with or without dietitian-led group support for weight loss in women treated for breast cancer : the BRIGHT (BReast cancer weIGHT loss) trial.(2019-02-13) Newlands, Rumana; Ntessalen, Maria; Clark, Julia; Fielding, Shona; Hoddinott, Pat; Heys, Steven Darryll; McNeill, Geraldine; Craig, Leone Christina Agnese; University of Aberdeen.Aberdeen Centre for Evaluation; University of Aberdeen.Other Applied Health Sciences; University of Aberdeen.Institute of Applied Health Sciences; University of Aberdeen.Applied Medicine; University of Aberdeen.Grampian Data Safe Haven (DaSH)Item Patient and primary care delays in the diagnostic pathway of gynaecological cancers : a systematic review of influencing factors(2019-02) Williams, Pauline; Murchie, Peter; Bond, Christine; University of Aberdeen.Other Applied Health Sciences; University of Aberdeen.Grampian Data Safe Haven (DaSH); University of Aberdeen.Institute of Applied Health Sciences; University of Aberdeen.Aberdeen Centre for Women’s Health ResearchItem The Chest Australia Trial : a randomised controlled trial of an intervention to increase consultation rates in smokers at risk of lung cancer(2019-04) Emery, Jon; Murray, Sonya R.; Walter, Fiona M.; Martin, Andrew; Goodall, Stephen; Mazza, Danielle; Habgood, Emily; Kutzer, Yvonne; Barnes, David J.; Murchie, Peter; University of Aberdeen.Other Applied Health Sciences; University of Aberdeen.Grampian Data Safe Haven (DaSH); University of Aberdeen.Institute of Applied Health SciencesItem Transcriptional Subtyping and CD8 Immunohistochemistry Identifies Patients With Stage II and III Colorectal Cancer With Poor Prognosis Who Benefit From Adjuvant Chemotherapy(2018-06-13) Allen, Wendy L.; Dunne, Philip D.; McDade, Simon; Scanlon, Enya; Loughrey, Maurice; Coleman, Helen G.; McCann, Christophe; McLaughlin, Kristy; Nemeth, Zsuzsanna; Syed, Najeeb Ashraf; Jithesh, Puthen Veettil; Arthur, Ken; Wilson, Richard; Coyle, Vicky M.; McArt, Darragh; Murray, Graeme L.; Samuel, Leslie; Nuciforo, Paolo; Jimenez, Jose; Argiles, Guillem; Dienstmann, Rodrigo; Tabernero, Josef; Picariello, Lucia; Messerini, Luca; Nobili, Stefania; Mini, Enrico; Sheahan, Kieran; Ryan, Elizabeth; Johnston, Patrick G.; Van Schaeybroeck, Sandra; Lawler, Mark; Longley, Daniel B.; University of Aberdeen.Applied Medicine; University of Aberdeen.Aberdeen Centre for EvaluationItem Preoperative chemoradiation with capecitabine, irinotecan and cetuximab in rectal cancer : significance of pre-treatment and post-resection RAS mutations(2017-10-24) Gollins, Simon; West, Nick; Sebag-Montefiore, David; Myint, Arthur Sun; Saunders, Mark; Susnerwala, Shabbir; Quirke, Phil; Essapen, Sharadah; Samuel, Leslie; Sizer, Bruce; Worlding, Jane; Southward, Katie; Hemmings, Gemma; Tinkler-Hundal, Emma; Taylor, Morag; Bottomley, Daniel; Chambers, Philip; Lawrie, Emma; Lopes, Andre; Beare, Sandy; University of Aberdeen.Aberdeen Centre for Evaluation